Kuratiert · Gesundheit

Lab tools & diagnostics

Von InspectStocksPublished 14. Okt. 202620 companies0 followers

Instruments, supplies and testing services for labs, drugmakers and doctors.

Mit Hilfe eines KI-Modells gruppiert und von unserer Redaktion geprüft. Die Zeile unter jedem Unternehmen sagt, warum es hier steht.

Download image

Karten Stufen

Aktienkurse sind die Schlusskurse vom 11. Nov. 2026, aus dem IEX-Börsenfeed.

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22,0 %

Sort by

TMOTHERMO FISHER SCIENTIFIC INC.
Diagnostics and researchMarket cap 265,9B $P/E 37,85
717,62 $+22,5 %1Y
Since added +8,2 %
A+
Wachstum und Cash
Wächst kräftig
Business trend
Beschleunigt
Business quality
Stark
Getting better
Verbessert sich
Revenue
47,4B $+8,3 %
Profit
7,1B $+7,6 %
Free cash flow
7,6B $+24,3 %
Discuss
Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
DHRDANAHER CORPORATION
Diagnostics and researchMarket cap 165,5B $P/E 38,51
235,31 $+8,0 %1Y
Since added +5,4 %
B+
Wachstum und Cash
Wächst kräftig
Business trend
Beschleunigt
Business quality
Stark
Getting better
Verbessert sich
Revenue
25,6B $+5,5 %
Profit
4,3B $+23,6 %
Free cash flow
5,7B $+14,2 %
Discuss
Why it is here: Sells research instruments, supplies and services
AAGILENT TECHNOLOGIES, INC.
Diagnostics and researchMarket cap 49,9B $P/E 34,89
176,91 $+17,6 %1Y
Since added +3,1 %
B+
Wachstum und Cash
Wächst kräftig
Business trend
Beschleunigt
Business quality
Stark
Getting better
Verbessert sich
Revenue
7,4B $+8,6 %
Profit
1,4B $+18,0 %
Free cash flow
1,3B $+16,5 %
Discuss
Why it is here: Sells lab instruments, consumables and software to labs and drug makers
WATWaters Corporation
Diagnostics and researchMarket cap 46,3B $P/E 202,08
470,84 $+21,5 %1Y
Since added +9,7 %
D
Wachstum und Cash
Wächst
Business trend
Verlangsamt
Business quality
Gemischt
Getting better
Gemischt
Revenue
5,6B $+84,2 %
Profit
98,6M $-84,8 %
Free cash flow
290,8M $-51,7 %
Discuss
Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
MTDMettler-Toledo International Inc.
Diagnostics and researchMarket cap 34,8B $P/E 37,95
1.749,30 $+20,8 %1Y
Since added +9,4 %
B+
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Stark
Getting better
Verbessert sich
Revenue
4,2B $+6,5 %
Profit
934,1M $+11,8 %
Free cash flow
870,6M $-2,1 %
Discuss
Why it is here: Makes precision laboratory instruments and weighing equipment
ILMNIllumina, Inc.
Diagnostics and researchMarket cap 32,2B $P/E 36,64
212,86 $+74,5 %1Y
Since added -21,5 %
A+
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Stark
Getting better
Verbessert sich deutlich
Revenue
4,5B $+5,8 %
Profit
895M $+27,5 %
Free cash flow
1,1B $+5,7 %
Discuss
Why it is here: Sells DNA sequencing instruments and reagents
IDXXIDEXX LABORATORIES INC /DE
Diagnostics and researchMarket cap 55,4B $P/E 47,37
703,00 $-1,5 %1Y
Since added +35,2 %
A+
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Stark
Getting better
Verbessert sich deutlich
Revenue
4,7B $+11,9 %
Profit
1,2B $+15,1 %
Free cash flow
1,3B $+35,3 %
Discuss
Why it is here: Sells veterinary diagnostic tests and instruments
DGXQuest Diagnostics Inc
Diagnostics and researchMarket cap 28,5B $P/E 25,77
258,72 $+40,8 %1Y
Since added +12,2 %
A
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Solide
Getting better
Verbessert sich
Revenue
11,8B $+9,1 %
Profit
1,1B $+16,5 %
Free cash flow
1,4B $-1,3 %
Discuss
Why it is here: Provides diagnostic testing and clinical lab services
LHLABCORP HOLDINGS INC.
Diagnostics and researchMarket cap 30,2B $P/E 30,53
372,18 $+41,3 %1Y
Since added +18,7 %
A
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Gemischt
Getting better
Verbessert sich deutlich
Revenue
14,6B $+6,0 %
Profit
1B $+17,4 %
Free cash flow
1,3B $-6,8 %
Discuss
Why it is here: Provides diagnostic tests and clinical lab services
RVTYREVVITY, INC
Diagnostics and researchMarket cap 17,7B $P/E 70,32
158,22 $+68,5 %1Y
Since added +2,0 %
A
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Gemischt
Getting better
Verbessert sich
Revenue
2,9B $+4,6 %
Profit
253,2M $+6,6 %
Free cash flow
590,5M $+18,7 %
Discuss
Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
IQVIQVIA HOLDINGS INC.
Diagnostics and researchMarket cap 45,2B $P/E 33,38
274,37 $+24,2 %1Y
Since added +5,2 %
A
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Gemischt
Getting better
Verbessert sich
Revenue
17,3B $+8,8 %
Profit
1,4B $+8,7 %
Free cash flow
2,1B $-6,0 %
Discuss
Why it is here: Runs clinical trials and sells healthcare data to drugmakers
NTRANATERA, INC.
Diagnostics and researchMarket cap 46,4B $Kein KGV (operativer Verlust)
319,77 $+52,6 %1Y
Since added -19,2 %
B-
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Schwach
Getting better
Gemischt
Revenue
2,9B $+37,4 %
Profit
-164,7M $+46,7 %
Free cash flow
52,5M $-50,5 %
Discuss
Why it is here: Provides genetic and cell-free DNA diagnostic tests
TECHBIO-TECHNE Corp
BiotechnologyMarket cap 11,4B $P/E 66,77
72,78 $+19,2 %1Y
Since added +0,4 %
A+
Wachstum und Cash
Wächst kräftig
Business trend
Beschleunigt
Business quality
Stark
Getting better
Verbessert sich deutlich
Revenue
1,2B $+0,9 %
Profit
172M $+120,5 %
Free cash flow
308,2M $+37,6 %
Discuss
Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
BRKRBRUKER CORPORATION
Medical devicesMarket cap 9,5B $Kein KGV (operativer Verlust)
62,41 $+47,5 %1Y
Since added +11,0 %
B
Wachstum und Cash
Wächst kräftig
Business trend
Verlangsamt
Business quality
Gemischt
Getting better
Gemischt
Revenue
3,5B $+2,2 %
Profit
-123,4M $-490,4 %
Free cash flow
244,7M $+2.408,5 %
Discuss
Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
RGENREPLIGEN CORP
Medical instruments and suppliesMarket cap 9,8B $No P/E
172,68 $+9,3 %1Y
Since added -1,6 %
B
Wachstum und Cash
Wächst kräftig
Business trend
Verlangsamt
Business quality
Gemischt
Getting better
Verbessert sich
Revenue
805,6M $+13,8 %
Profit
-11,8M $-779,2 %
Free cash flow
106,7M $-3,0 %
Discuss
Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
BIOBIO-RAD LABORATORIES, INC.
Medical devicesMarket cap 10,4B $Kein KGV (operativer Verlust)
386,08 $+18,0 %1Y
Since added +6,1 %
C
Wachstum und Cash
Wächst
Business trend
Stabil
Business quality
Solide
Getting better
Verbessert sich
Revenue
2,6B $+1,4 %
Profit
1B $+251,3 %
Free cash flow
329,1M $-2,3 %
Discuss
Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
QGENQIAGEN N.V.
Diagnostics and researchMarket cap 10,9B $P/E 25,93
50,30 $+19,8 %1Y
Since added +10,7 %
B+
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Stark
Getting better
Verbessert sich
Revenue
2,1B $+2,1 %
Profit
384,5M $-5,2 %
Free cash flow
436,2M $-8,9 %
Discuss
Why it is here: Supplies sample preparation and molecular testing kits and instruments
GHGUARDANT HEALTH, INC.
Diagnostics and researchMarket cap 20,9B $Kein KGV (operativer Verlust)
154,76 $+58,2 %1Y
Since added -4,5 %
B
Wachstum und Cash
Wächst kräftig
Business trend
Stabil
Business quality
Gemischt
Getting better
Gemischt
Revenue
1,3B $+41,7 %
Profit
-485,1M $-21,6 %
Free cash flow
-232,1M $+11,5 %
Discuss
Why it is here: Provides blood-based cancer diagnostic tests
MEDPMedpace Holdings, Inc.
Diagnostics and researchMarket cap 18,6B $P/E 36,90
664,52 $+11,2 %1Y
Since added +9,0 %
C+
Wachstum und Cash
Wächst kräftig
Business trend
Verlangsamt
Business quality
Stark
Getting better
Verbessert sich deutlich
Revenue
2,8B $+20,4 %
Profit
517,8M $+19,6 %
Free cash flow
667,6M $-1,4 %
Discuss
Why it is here: Runs clinical trials for biotech and pharma drug developers
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Diagnostics and researchMarket cap 16,4B $P/E 353,20
342,61 $+99,8 %1Y
Since added +14,5 %
F
Wachstum und Cash
Gemischt
Business trend
Schrumpfend
Business quality
Gemischt
Getting better
Gemischt
Revenue
4B $-1,2 %
Profit
40,2M $+148,8 %
Free cash flow
399,6M $-26,5 %
Discuss
Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Be civil and stick to the companies. Comments are opinions, not advice.

Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.